Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Not applicableActive Not RecruitingNCT07754019
What this trial is testing

Serum and Urinary sCD163 in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Bezmialem Vakif University 87
Testing effectiveness (Phase 2)UnknownNCT00569101
What this trial is testing

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Seoul National University Hospital 9
Not applicableStudy completedNCT00983034
What this trial is testing

The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

Who this might be right for
Nephrotic SyndromeGlomerulonephritisMembranous Nephropathy
Istanbul University 70
Not applicableStudy completedNCT00298506
What this trial is testing

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06607016
What this trial is testing

A Clinical Trial With KJ103 in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Disease
Shanghai Bao Pharmaceuticals Co., Ltd. 12
Large-scale testing (Phase 3)Ended earlyNCT02514967
What this trial is testing

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 3
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableStudy completedNCT04092491
What this trial is testing

Study of the IgA Repertoire During IgA Deposition Nephropathy.

Who this might be right for
Glomerulonephritis, IGA
University Hospital, Limoges 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05799287
What this trial is testing

Telitacicept for IgA Nephropathy (TELIGAN)

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 318
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Testing effectiveness (Phase 2)UnknownNCT03580291
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Lingyun Sun 230
Testing effectiveness (Phase 2)Study completedNCT03945318
What this trial is testing

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 103
Testing effectiveness (Phase 2)Study completedNCT03124368
What this trial is testing

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

Who this might be right for
C3 GlomerulonephritisDense Deposit DiseaseC3 Glomerulopathy+2 more
Alexion Pharmaceuticals, Inc. 6
Not applicableUnknownNCT04805047
What this trial is testing

SodiUm Restriction by Behavioral Intervention

Who this might be right for
IgA Nephropathy
First Affiliated Hospital Xi'an Jiaotong University 142
Testing effectiveness (Phase 2)Study completedNCT06513338
What this trial is testing

Complement C5 mAb in the Treatment of Anti-GBM Disease

Who this might be right for
Autoimmune Diseases
Peking University First Hospital 16
Not applicableStudy completedNCT03880643
What this trial is testing

Rituximab in Refractory Primary Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Istanbul University 36
Testing effectiveness (Phase 2)UnknownNCT04846010
What this trial is testing

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Who this might be right for
Sequelae of; InfectionPost Infection GlomerulonephritisPost-Infectious Peripheral Neuralgia+15 more
All Natural Medicine Clinic, LLC 2,000
Testing effectiveness (Phase 2)Study completedNCT05856760
What this trial is testing

Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

Who this might be right for
Immunoglobulin A Nephropathy
Travere Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT02062684
What this trial is testing

BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration

Who this might be right for
IgA Nephropathy
Anthera Pharmaceuticals 57
Next Page